The weight loss ‘quick fix’ driving a wave of hospitalisations (opens original article in a new tab)
Unapproved peptides marketed for weight loss are causing hospitalisations due to severe liver toxicity, with cases reported in Victoria and other Australian regions.
- Six people in Victoria experienced acute liver toxicity from unapproved peptide Retatrutide
- Similar cases reported in other Australian regions
- Unapproved peptides marketed with unproven weight loss benefits
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.